ArticleJAAD case reports2023

Letter in response to the case report "Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis".

Meron Teklu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.